Searle to launch a lifesaving drug for hospitalized COVID19 patients

Karachi, May 30, 2020: The Searle Company Limited has successfully entered into an exclusive licensing & marketing agreement with Beximco Pharmaceuticals, Bangladesh. Searle is the first and only pharmaceutical company in Pakistan to source the generic version of Remdesivir for the treatment of Covid-19 through the Patient Access Program. Remdesivir is a direct acting broad-spectrum…

Read More

Voluntary Licensing agreements for Remdesivir

“Ferozsons Laboratories from Pakistan is amongst the five companies to produce Remdesivir for distribution in 127 countries” Karachi, May 13, 2020: Gilead has signed non-exclusive voluntary licensing agreements with five generic pharmaceutical manufacturers based in India and Pakistan to further expand supply of Remdesivir. The agreements allow the companies – Cipla Ltd, Ferozsons Laboratories, Hetero…

Read More